UK regulator finds Pfizer boss guilty of misinformation

Pfizer: sales before child safety
UsForThem submitted a complaint to the UK’s Prescription Medicines Code of Practice Authority — the regulator responsible for policing promotions of prescription medicines in the UK. The complaint cited the overtly promotional nature of the BBC’s reports and challenged the compliance of Dr Bourla’s comments about children with the apparently strict rules governing the promotion of medicines in the UK.

More than a year later…the complaint and all of the PMCPA’s findings have been made public in a case report published on the regulator’s website (https://www.pmcpa.org.uk/cases/completed-cases/auth35911221-a-complaint-on-behalf-of-usforthem-v-pfizer/).
….importantly an industry-appointed appeal board affirmed the PMCPA’s original findings that Dr Bourla’s comments on vaccinating 5 to 11-year-olds were promotional, and were both misleading and incapable of substantiation in relation to the safety of vaccinating that age group.

https://usforthem2020.substack.com/p/pfizer-sales-before-child-safety